Performance Food Group Reports Mixed Q3 Results: Sales & Adjusted EBITDA Up, GAAP Net Income Down, JUUL Litigation Resolved

summarizeSummary

Performance Food Group reported increased net sales and Adjusted EBITDA for Q3 fiscal 2026, but GAAP net income and diluted EPS decreased. The company also announced the resolution of the JUUL litigation and reduced share repurchase activity.

check_boxKey Events

• Mixed Financial Performance

  For Q3 fiscal 2026, net sales increased by 6.4% to $16.29 billion and Adjusted EBITDA rose by 6.6% to $410.6 million. However, GAAP net income decreased by 28.5% to $41.7 million, and diluted EPS fell by 27.0% to $0.27, primarily due to higher operating and interest expenses.

• JUUL Litigation Resolved

  The company announced that its subsidiaries, Eby-Brown and Core-Mark, have been released from the Multidistrict Litigation (MDL) settlement related to JUUL Labs, Inc., and the parallel Illinois litigation has also been resolved, removing a significant legal contingency.

• Reduced Share Repurchase Activity

  During Q3 fiscal 2026, the company repurchased only $1.2 million in common stock, a significant decrease compared to $10.6 million in the prior-year quarter. Approximately $498.8 million remains available under the $500 million authorization.

• Debt Refinancing and Compliance

  Performance Food Group refinanced $1.06 billion of 5.500% Senior Notes due 2027 with new 5.625% Senior Notes due 2034. The company remains in compliance with all debt covenants, and the average interest rate on its ABL Facility decreased to 5.30%.

auto_awesomeAnalysis

Performance Food Group's latest 10-Q provides a detailed look into its fiscal Q3 2026 performance, following the preliminary announcement in an 8-K. While the company achieved robust net sales and Adjusted EBITDA growth, its GAAP net income and diluted EPS declined for both the quarter and year-to-date periods. This mixed financial picture is crucial for investors to understand the underlying operational strengths versus the impact of increased operating and interest expenses. The resolution of the significant JUUL litigation removes a notable legal overhang, which is a positive development. However, the substantial reduction in share repurchase activity compared to the prior year suggests a shift in capital allocation priorities or market conditions. Investors should monitor the company's ability to translate strong top-line growth and Adjusted EBITDA into improved GAAP profitability in future periods, especially given the ongoing share repurchase program headroom.